FCF co-organized, together with its partner YAFO Capital, the “ACCESS CHINA Biotech Forum” which was held online on June 21st & 24th, 2022.
ACCESS CHINA Biotech Forum is a quarterly corporate access event series between China and western biopharma. It is the most effective deal-making platform for western pharma and biotech leaders looking to enter or expand in the Chinese market. The event helps western biopharma companies to efficiently present their assets online in front of 500+ biopharma companies / 2000+ BD directors and healthcare VCs in China. It creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. We hosted 100 company presentations, 10 keynote speeches, 1000+ participants, and 250+ 1×1 meetings. Licensing activity in China has been steadily increasing over the years.